A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease
The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by...
Study revealed a new way to infiltrate hard-to-treat cancers, unlocking key to potential treatments.
An antibody linked with two different antitumor drugs (dual-drug antibody-drug conjugate) is binding to a cancer cell, exhibiting a synergistic cell-killing effect. (Photo courtesy of Kyoji Tsuchikama, PhD)
There are now several monoclonal antibodies, identical copies of a therapeutic antibody produced in large numbers, that are authorized for the treatment of COVID-19.
Scientists create a hybrid antibody that can sharply cut the amount of SARS-CoV-2 in the lungs of infected mice.
Zhiqiang An, PhD, was one of the lead authors of a study that revealed engineered IgM antibodies were more potent than standard ones against COVID-19. (Photo by UTHealth)
Researchers with UTHealth have found a possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials.
Researchers have discovered a potential new antibody therapy for COVID-19. (Photo by UTHealth)
A new study found a protein linked to Alzheimer’s Disease also contributes to problems with diabetes and obesity.
The University of Kentucky College of Agriculture, Food and Environment today inducted four new members into its Hall of Distinguished Alumni.
The Food and Drug Administration approved a record-breaking 59 new drugs and biologics in 2018 – nearly double its average of 33 new drugs per year.
Five innovative cancer-fighting projects at The University of Texas Health Science Center at Houston (UTHealth) received just over $11 million during the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas (CPRIT).
The hormone leptin is produced by fat cells and increases with obesity, leading to high levels of leptin in the blood.
Each year in the U.S., about 20,000 new cases of AML are diagnosed and more than 10,000 people die of the disease.
Proteases in Some Cancer Cells Have the Ability to Break Antibodies by Taking Them Off Their Hinges
Exclusive global license agreements are most financially significant for UT Health San Antonio, with initial $4.5M payment plus royalties.
Antibody Drug Discovery
